CD36: an emerging therapeutic target for cancer and its molecular mechanisms Chengwei RuanYankai MengHu Song Review – Cancer Research 27 February 2022 Pages: 1551 - 1558
Evaluation of prevention behaviour and its influencing factors with respect to cancer screening Adam DawidChristoph BorzikowskyKatrin Hertrampf Original Article – Cancer Research Open access 07 March 2022 Pages: 1559 - 1567
The role of miR-370 and miR-138 in the regulation of BMP2 suppressor gene expression in colorectal cancer: preliminary studies Agnieszka PiechowskaCelina Kruszniewska-RajsStanisław Głuszek Original Article – Cancer Research 15 March 2022 Pages: 1569 - 1582
Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer Xuan WangKeying CheJia Wei Original Article – Cancer Research 16 March 2022 Pages: 1583 - 1595
Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosis Hongpan ZhangMeihan LiuBangxian Tan Original Article – Cancer Research 17 March 2022 Pages: 1597 - 1612
Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer Yong LiuTao WangJun Liu Original Article – Cancer Research 21 March 2022 Pages: 1613 - 1626
Histone methyltransferase KMT2C plays an oncogenic role in prostate cancer Jianpo LianChengdang XuDenglong Wu Original Article – Cancer Research 23 March 2022 Pages: 1627 - 1640
Nuclear respiratory factor 1 transcriptomic signatures as prognostic indicators of recurring aggressive mesenchymal glioblastoma and resistance to therapy in White American females Kaumudi BhaweJayanta K. DasDeodutta Roy Original Article – Cancer Research 20 April 2022 Pages: 1641 - 1682
Correction to: Three-dimensional models: a novel approach for lymphoma research Maura RossiFrancesco AlvianoClaudio Agostinelli Correction 17 May 2022 Pages: 1683 - 1683
Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis Tian-Run LvHai-Jie HuFu-Yu Li Review – Clinical Oncology 24 February 2022 Pages: 1685 - 1696
Management of secondary Paget’s disease of the vulva associated with transitional cell carcinoma S. KajtezovicAllison R. WalkerC. Wong Review – Clinical Oncology 17 April 2022 Pages: 1697 - 1702
Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma Ofer MargalitShun YuBen Boursi Original Article – Clinical Oncology 23 January 2022 Pages: 1703 - 1708
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma Ofer MargalitShun YuBen Boursi Correction 02 June 2022 Pages: 1709 - 1709
Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study Benedikt KowalskiAlan ValapertiDaniel Franzen Original Article – Clinical Oncology Open access 04 August 2021 Pages: 1711 - 1720
The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer Fen WangFeng JinShubin Wang Original Article – Clinical Oncology 06 August 2021 Pages: 1721 - 1735
Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world Sawako KakuHidehito HorinouchiMasahiko Kusumoto Original Article – Clinical Oncology Open access 07 February 2022 Pages: 1737 - 1746
Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world Sawako KakuHidehito HorinouchiMasahiko Kusumoto Correction Open access 02 June 2022 Pages: 1747 - 1747
3D T1-weighted turbo spin echo contrast-enhanced MRI at 1.5 T for frameless brain metastases radiotherapy Jing YuanStephen C. K. LawKin Yin Cheung Original Article – Clinical Oncology 06 August 2021 Pages: 1749 - 1759
Differential diagnosis of appendiceal serrated lesions and polyps and low-grade appendiceal mucinous neoplasm: analysis of 88 cases Yiyan LuChanghai QiMulan Jin Original Article – Clinical Oncology 09 August 2021 Pages: 1761 - 1769
Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients Gang WuWeiyuan HuangMengsen Li Original Article – Clinical Oncology 16 August 2021 Pages: 1771 - 1780
Drug-eluting bead trans-arterial chemoembolization combined with microwave ablation therapy vs. microwave ablation alone for early stage hepatocellular carcinoma: a preliminary investigation of clinical value Juanfang LiuWenguang ZhangXinwei Han Original Article – Clinical Oncology Open access 17 August 2021 Pages: 1781 - 1788
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies Niklas GebauerBritta MenglerHanno M. Witte Original Article – Clinical Oncology Open access 20 August 2021 Pages: 1789 - 1801
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy Ta-Chen HuangCher-Wei LiangChih-Hung Hsu Original Article – Clinical Oncology 25 August 2021 Pages: 1803 - 1811
Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression Yuchen XieSongyi NingJianpeng Hu Review Open access 28 May 2022 Pages: 1813 - 1823
A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing: a case report Xiaoyi XuHaoyi WangXianguo Chen Letter to the Editors 02 April 2022 Pages: 1825 - 1827
Retraction Note to: Screening and identification of gastric adenocarcinoma metastasis-related genes using cDNA microarray coupled to FDD-PCR Jianhua WangShishu Chen Retraction Note 20 May 2022 Pages: 1829 - 1829